Rapid Results

Coronavirus (COVID-19)/Influenza A/B (Flu A/B)/Respiratory Syncytial Virus (RSV) Antigen Combo Rapid Test

Name: Coronavirus (COVID-19)/Influenza A/B (Flu A/B)/Respiratory Syncytial Virus (RSV) Antigen Combo Rapid Test
Brand: reOpenTest
SKU: VIR-CFRV10
Availability: InStock

Simultaneous detection of COVID-19, Influenza A/B, and Respiratory Syncytial Virus (RSV) antigens.

CE Certified

ISO 13485

Request Quote View Specs

Main image of Coronavirus (COVID-19)/Influenza A/B (Flu A/B)/Respiratory Syncytial Virus (RSV) Antigen Combo Rapid Test

Why Choose reOpenTest Infectious Disease Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Fast Results

Provides results in 15-20 minutes for rapid diagnosis.

Multiple Targets

Detects COVID-19, Influenza A/B, and RSV simultaneously.

Easy to Use

Simple, easy-to-follow procedure for various settings.

Product Overview

The Coronavirus (COVID-19)/Influenza A/B (Flu A/B)/Respiratory Syncytial Virus (RSV) Antigen Combo Rapid Test is an in-vitro diagnostic device for the simultaneous detection of antigens from SARS-CoV-2, Influenza A, Influenza B, and RSV in nasal or nasopharyngeal swab specimens. It aids in quick diagnosis and management of respiratory infections.

Technical Specifications

Detection Target	SARS-CoV-2, Influenza A, Influenza B, RSV Antigens
Sample Type	Nasal or Nasopharyngeal Swab
Methodology	Immunochromatography
Detection Range	Positive/Negative
Reaction Time	15-20 minutes
Storage Conditions	2-30u00b0C
Shelf Life	24 months

Procedure & Interpretation

Step-by-Step Procedure

Collect nasal or nasopharyngeal swab sample.
Apply sample to the test device.
Wait 15-20 minutes.
Read and interpret the results.

Result Interpretation

Positive: Visible lines for any of the target viruses indicate a positive result for that virus.

Negative: Only the control line is visible, indicating a negative result.

Invalid: If the control line is not visible, the test is invalid and should be repeated.

Frequently Asked Questions

This test enables rapid differentiation between COVID-19, Flu A/B, and RSV, allowing for appropriate treatment decisions, isolation protocols, and resource allocation to manage patient flow effectively.

The recommended sample types are nasal and nasopharyngeal swabs, collected according to standard clinical procedures.

While PCR testing is considered the gold standard, this rapid antigen test offers a convenient and quick alternative for initial screening, particularly in point-of-care settings where immediate results are needed. Confirm with PCR for uncertain results.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Coronavirus (COVID-19)/Influenza A/B (Flu A/B)/Respiratory Syncytial Virus (RSV) Antigen Combo Rapid Test